These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 16952668)

  • 1. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
    Goh AC; Gonzalez RR
    J Urol; 2010 Apr; 183(4):1469-73. PubMed ID: 20172555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
    Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
    J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial.
    Elzayat EA; Al-Mandil MS; Khalaf I; Elhilali MM
    J Urol; 2009 Jul; 182(1):133-8. PubMed ID: 19447438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial.
    Elmansy HM; Elzayat E; Elhilali MM
    J Urol; 2010 Nov; 184(5):2023-8. PubMed ID: 20850828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.
    Arai Y; Aoki Y; Okubo K; Maeda H; Terada N; Matsuta Y; Maekawa S; Ogura K
    J Urol; 2000 Oct; 164(4):1206-11. PubMed ID: 10992367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KTP/LBO laser vaporization of the prostate.
    Wosnitzer MS; Rutman MP
    Urol Clin North Am; 2009 Nov; 36(4):471-83, vi. PubMed ID: 19942046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
    Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
    J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
    Yu B; Wang Z
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population.
    Hai MA
    Urology; 2009 Apr; 73(4):807-10. PubMed ID: 19200589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoselective vaporization for benign prostatic hyperplasia.
    Murtagh J; Foerster V
    Issues Emerg Health Technol; 2006 Dec; (95):1-4. PubMed ID: 17176529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.